Distinct roles of prostaglandin H synthases 1 and 2 in T-cell development

Journal of Clinical Investigation

Volumn 103, Issue 10, 1999, Pages 1469-1477

  Rocca, Bianca ^a   Spain, Lisa M ^b   Puré, Ellen ^b   Langenbach, Robert ^c   Patrono, Carlo ^d   FitzGerald, Garret A ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b WISTAR INSTITUTE   (United States)

^c NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^d UNIVERSITY OF CHIETI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTAGLANDIN SYNTHASE;

ANIMAL EXPERIMENT; ARTICLE; CELL LINEAGE; ENZYME ACTIVITY; ENZYME LOCALIZATION; HELPER CELL; KNOCKOUT MOUSE; LYMPHOCYTE DIFFERENTIATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; T LYMPHOCYTE ACTIVATION;

EID: 0032696786     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI6400     Document Type: Article

References (51)

1. Smith, W.L., and DeWitt, D.L. 1996. Prosraglandin endoperoxide H synthases -1 and -2. Adv. Immunol. 62:167-215.
2. Herschman, H.R., Reddy, S.T., and Xie, W. 1997. Function and regulation of prostaglandin synthase-2. Adv. Exp. Med. Biol. 407:61-66.
3. 2 inhibits production of Th1 lymphokines but not of Th2 lymphokines. J. Immunol. 146:108-113.
4. 2 and other cyclic AMP-elevating agents modulate IL-2 and IL-2R alpha gene expression at multiple levels. J. Immunol. 148:2845-2852.
5. 2 and other cyclic AMP elevating agents inhibit interleukin 2 gene transcription by counteracting calcineurin-dependent pathways. J. Exp. Med. 178:1813-1817.
6. 2 critically depends on interleukin 2. Eur. J. Immunol. 25:59-63.
7. + T-cells inhibits acquisition of ability to produce IFN-γ and IL-2, but not IL-4 and IL-5. J. Immunol. 155:4604-4612.
8. 2 is a potent inhibitor of human interleukin 12 production. J. Exp. Med. 181:775-779.
9. 2 receptors of the EP2 and EP4 subtypes regulate activation and differentiation of mouse B lymphocytes to IgE-secreting cells. Proc. Natl. Acad. Sci. USA. 93:10978-10983.
10. 2 production by macrophages infected with HIV. Cell. Immunol. 152:120-130.
11. 2. AIDS. 9:441-445.
12. 2 levels found in 14 patients undergoing autologous bone marrow or stem cell transplantation. Bone Marrow Transplant. 12:603-608.
13. Leung, D.Y. 1995. Atopic dermatitis: the skin as a window into the pathogenesis of chronic allergic diseases. J. Allergy Clin. Immunol. 96:302-318.
14. Nusing, R., et al. 1992. Localization of thromboxane synthase in human tissues by monoclonal antibody Tu 300. Virchows Arch. A Pathol. Anat. Histopathol. 421:249-254.
15. Ushikubi, F., Hirata, M., and Narumiya, S. 1995. Molecular biology of prostanoid receptors: an overview. J. Lipid Mediat. Cell Signal. 12:343-359.
16. Appasamy, P.M., et al. 1991. Expression of prostaglandin G/H synthase (cyclooxygenase) during murine fetal thymic development. Cell. Immunol. 137:341-357.
17. Milicevic, N.M., Appasamy, P.M., Colic, M., and Milicevic, Z. 1994. Immunocytochemical demonstration of prostaglandin synthase (cyclooxygenase) in thymic macrophages of normal and cyclosporin-treated rats. Immunobiology. 190:376-384.
18. Sun, L., Piltch, A.S., Liu, P., Johnson, A., and Hayashi, J. 1990. Thymocytes stimulate metabolism of arachidonic acid in rat epithelial cells. Cell. Immunol. 131:86-97.
19. McCormack, J.E., Kappler J., Marrack, P., and Westcott, J.Y. 1991. Production of prostaglandin E2 and prostacyclin by thymic nurse cells in culture. J. Immunol. 146:239-243.
20. Pendino, K.J., Chepenik, K.P., and Schmidt, R.R. 1992. Differential eicosanoid synthesis by murine fetal thymic non-lymphoid cells. Immunol. Cell Biol. 70:237-252.
21. Morham, S. F., et al. 1995. Prostaglandin synthase gene disruption causes severe renal pathology in the mouse. Cell. 83:473-482.
22. Langenbach, R., et al. 1995. Prostaglandin synthase-1 gene disruption in mice reduce arachidonic acid-induced inflammation and indomethacin-induced gastric ulceration. Cell. 83:483-492.
23. Kisielow, P. 1990. Applications of fetal thymus organ cultures in studies of T-cell development. In Immunological methods, volume 4. I. Lefkovits and B. Pernis, editors. Academic Press. San Diego, CA. 292-309.
24. Arakawa, T., et al. 1996. Prostanoid receptors of murine NIH 3T3 and RAW 264.7 cells. Structure and expression of the murine prostaglandin EP4 receptor gene. J. Biol. Chem. 271:29569-29575.
25. Fedyk, E.R., Ripper, J.M., Brown, D.M., and Phipps, R.P. 1996. A molecular analysis of the PGE receptor (EP) expression on normal and transformed B lymphocytes: coexpression of the EP1, EP2, EP3, and EP4. Mol. Immunol. 33:33-45.
26. Habib, A., et al. 1993. Demonstration of an inducible cyclooxygenase in human endothelial cells using anybodies raised against the carboxyl-terminal region of the cyclooxygenase-2. J Biol Chem. 268:23448-23454.
27. Jenkinson, E.J., and Owen, J.J. 1990. T-cell differentiation in thymus organ cultures. Semin. Immunol. 2:51-58.
28. Bhattacharyya, D.K., Lecomte, M., Dunn, J., Morgans, D.J., and Smith, W.L. 1995. Selective inhibition of prostaglandin endoperoxide synthase-1 (cyclooxygenase-1) by valeryl salicylic acid. Arch. Biochem. Biophys. 317:19-24.
29. Rocca, B., Spain, L.M., Ciabattoni, G., Patrono, C. and FitzGerald, G.A. 1999. Differential expression and regulation of cyclooxygenase enzymes in thymic stromal cells. J. Immunol. 162:4589-4597.
30. Patrignani, P., et al. 1994. Biochemical and pharmacological characterization of the cyclooxygenase activity of human blood prostaglandin endoperoxide synthases. J. Pharmacol. Exp. Ther. 271:1705-1712.
31. Smith, W.L., and DeWitt, D.L. 1995. Biochemistry of prostaglandin endoperoxide H synthase-1 and synthase -2 and their differential susceptibility to nonsteroidal anti-inflammatory drugs. Semin. Nephrol. 15:179-194.
32. Mombaerts, P., et al. 1992. RAG-1 deficient mice have no mature B and T-lymphocytes. Cell. 68:869-877.
33. Levelt, C.N., Mombaerts, P., Iglesias, A., Tonegawa, S., and Eichmann, K. 1993. Restoration of early thymocyte differentiation in T-cell receptor β-chain deficient mutant mice by transmembrane signaling through CD3ε. Proc. Natl. Acad. Sci. USA. 90:11410-11415.
34. Panara, M.R., et al. 1995. Effects of the novel anti-inflammatory compounds, N-[2-(cyclohexyloxy)-4-nitrophenyl] merthanesulphonamide (NS-398) and 5-methane-sulphonamido-6-(2,4-difluorothio-phenyl)-1-indanone (L-745,337), on the cyclooxygenase activity of human blood prostaglandin endoperoxide synthases. Br. J. Pharmacol. 116:2429-2434.
35. Godfrey, D.I., Kennedy, J., Suda, T., and Zlotnik, A. 1993. A developmental pathway involving four phenotypically and functionally distinct subsets of CD3-DN triple negative adult mouse thymocytes defined by CD44 and CD25 expression. J. Immunol. 150:4244-4252.
36. 2. J. Immunol. 155:4437-4444.
37. O'Neill, G.P., and Ford-Hutchinson, A.W. 1993. Expression of mRNA for cyclooxygenase-1 and cyclooxygenase-2 in human tissues. FEBS Lett. 330:156-160.
38. Saint-Ruf, C., et al. 1994. Analysis and expression of a cloned pre-T-cell receptor gene. Science. 266:1208-1212.
39. Berger, M.A., et al. 1997. Subunit composition of pre-T-cell receptor complexes expressed by primary thymocytes: CD3ε is physically associated but not functionally required. J. Exp. Med. 186:1461-1467.
40. Miyazaki, T. 1997. Two distinct steps during thymocyte maturation from CD4-CD8-to CD4+CD8+ distinguished in the early growth response (Egr)-1 transgenic mice with a recombinase-activating genedeficient background. J. Exp. Med. 186:877-885.
41. 2 of activation-induced apoptosis of human DP T lymphoblasts. J. Immunol. 154:1041-1047.
42. 2 upon differentiation and programmed cell death of suspension cultured CD4-CD8-thymocytes. Int. J. Immunopharmacol. 16:775-786.
43. Kirtikara, K., et al. 1998. Compensatory prostaglandin E2 biosynthesis in cyclooxygenase 1 or 2 null cells. J. Exp. Med. 187:517-523.
44. + thymocytes in vitro. J. Exp. Med. 179:2027-2031.
45. Pénit, C., Lucas, B., and Vasseur, F. 1995. Cell expansion and growth arrest phase from precursor (CD4-8-) to immature (CD4+8+) thymocytes in normal and genetically modified mice. J. Immunol. 154:5103-5113.
46. Falk, I., Biro, J., Kohler, H., and Eichmann, K. 1996. Proliferation kinetics associated with T-cell receptor-beta chain selection of fetal murine thymocytes. J. Exp. Med. 184:2327-2339.
47. Halvorson, M.J., and Coligan, J.E. 1995. Enhancement of VLA integrin receptor function on thymocytes by cAMP is dependent on the maturation stage of the thymocytes. J. Immunol. 155:4567-4574.
48. Wang, T., Sheppard, J.R., and Foker, J.E. 1978. Rise and fall of cyclic AMP is required for onset of lymphocyte A synthesis. Science. 211:155-157.
49. Scheuer, W.V., Hobbs, M.V., and Weigle, W.O. 1987. Interference with tolerance induction in vivo by inhibitors of prostaglandin synthesis. Cell. Immunol. 104:409-418.
50. Ruiz, P., Woodson, C., and Rev, L. 1992. Modification of rat skin allograft rejection by inhibition of thromboxane synthesis. Transplantation. 54:385-387.
51. Remuzzi, G., et al. 1994. Thromboxane A2 receptor blocking abrogates donor specific unresponsiveness to renal allografts induced by rhymic recognition of major histocompatibility allopeptides. J. Exp. Med. 180:1967-1972.